Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / T••• H•••••• I•••

T••• H•••••• I•••

Series AHouston, TXBiotechnology
Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
$30.0Msum of rounds with a disclosed amount only
Named investors
3
Financing history
2 rounds
  1. Jul 21, 2026
    Series A · $30.0M (disclosed)
    N•••••• C•••••• P••••••• (participant)V•••••• C•••••• M••••••••• L•• (lead) via Greg BankerM••••• C•••••• P••••••• F•••• (lead) via Liz Todia Zambory
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “T••• H••••• Announces $30 Million Series A Financing to Expand Access to the B3 GEL® System”
  2. Jan 17, 2025
    Form D equity offering · $1.1M (form d sold) · 8 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “T••• H•••••• I••• filed Form D: $1,084,679 sold of $2,000,000, Biotechnology”
Investors on record
3 edges
People
2 officers, 6 directors
Timeline
3
  1. Jul 21, 2026
    T••• H••••• announced Series A of $30,000,000, led by V•••••• C••••••, M••••• C•••••• P•••••••
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  2. Nov 26, 2025
    T••• H•••••• I••• filed Form D/A: $7,142,974 sold of $7,918,951, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Jan 31, 2025
    T••• H•••••• I••• filed Form D: $1,084,679 sold of $2,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
31 observations
Every observation on this company